Although several molecular mechanisms as discussed above have been described to account for the potent antitumor activities exerted by ART, its potential effect on p38/ERK/STAT5/CREB signal transduction pathways in human CML cells has never been investigated before. Here, STAT5A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.